Omnicell (NASDAQ:OMCL) Releases Q2 Earnings Guidance

Omnicell (NASDAQ:OMCL) updated its second quarter earnings guidance on Thursday. The company provided EPS guidance of $0.10-0.20 for the period, compared to the consensus EPS estimate of $0.27. The company issued revenue guidance of $250-260 million, compared to the consensus revenue estimate of $261.84 million. Omnicell also updated its FY24 guidance to $0.90-1.40 EPS.

Omnicell Trading Up 2.9 %

Shares of OMCL stock opened at $30.13 on Friday. Omnicell has a 1-year low of $25.69 and a 1-year high of $77.14. The company has a current ratio of 2.38, a quick ratio of 2.22 and a debt-to-equity ratio of 0.48. The stock’s fifty day simple moving average is $27.73 and its 200-day simple moving average is $31.72.

Omnicell (NASDAQ:OMCL) last released its earnings results on Thursday, February 8th. The company reported $0.12 earnings per share for the quarter, beating the consensus estimate of ($0.10) by $0.22. The company had revenue of $258.85 million for the quarter, compared to analysts’ expectations of $256.00 million. Omnicell had a positive return on equity of 2.41% and a negative net margin of 1.91%. On average, sell-side analysts expect that Omnicell will post 0.09 earnings per share for the current fiscal year.

Analyst Ratings Changes

Several equities analysts have recently commented on OMCL shares. Benchmark restated a buy rating and set a $38.00 price target on shares of Omnicell in a report on Tuesday, April 30th. Wells Fargo & Company lowered their target price on Omnicell from $28.00 to $26.00 and set an equal weight rating on the stock in a research note on Friday, February 9th. One investment analyst has rated the stock with a sell rating, three have issued a hold rating and three have issued a buy rating to the company. According to data from MarketBeat.com, the stock currently has an average rating of Hold and a consensus target price of $42.20.

Omnicell Company Profile

Omnicell, Inc, together with its subsidiaries, provides medication management solutions and adherence tools for healthcare systems and pharmacies the United States and internationally. The company offers point of care automation solutions to improve clinician workflows in patient care areas of the healthcare system; XT Series automated dispensing systems for medications and supplies used in nursing units and other clinical areas of the hospital, as well as specialized automated dispensing systems for operating room; and robotic dispensing systems for handling the stocking and retrieval of boxed medications.